William M. Wilson1, MBBS, FRACP; Simon Walsh3, MD, FRCP; Colm Hanratty3, MD, FRCPI; Julian Strange4, MBChB, FRCP, MD; Jonathan Hill5, MA, MBChB, MRCP; James Sapontis5, MBBCh, BSc, FRACP; James C Spratt1,2*, BSc, MD, FRCP, FESC, FACC
1. Edinburgh Heart Centre, Little France, Edinburgh, Scotland, United Kingdom; 2. Forth Valley Royal Hospital, Larbert, Scotland, United Kingdom; 3. Belfast Health and Social Care Trust, Northern Ireland, United Kingdom; 4. Bristol Heart Institute, Bristo
Aims: Chronic total occlusions (CTO) secondary to in-stent restenosis (ISR) represent challenging lesions with low PCI success rates. The CrossBoss is an over-the-wire blunt catheter whic